PDX-Derived Ovarian Cancer Organoid Model

The ovarian cancer PDX models have become an essential tool in cancer research, offering a reliable and reproducible system for studying the disease's biology and testing potential therapies. These patient-derived xenograft (PDX) models provide an opportunity to better understand ovarian cancer's complex mechanisms, allowing researchers to identify new biomarkers and therapeutic targets. With the ability to closely replicate human tumor characteristics, ovarian cancer PDX models are pivotal for evaluating drug efficacy and advancing precision medicine. Researchers increasingly rely on these models to bridge the gap between preclinical findings and clinical trials, fostering the development of more effective treatments.